Delivery Order SPE2DB20D1100-SPE2DB24FD2W6
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,171.85, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 29, 2023. This award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract, valued at $3,268.33, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of October 30, 2023 and was awarded on October 27, 2022. This contract is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,966.93, is for the delivery of 4563374242 - Oxcarbazepine 300 mg/5 ml Suspension 250 ml. The contract is a Delivery Order with a Firm Fixed Price type and has an ultimate completion date of January 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,025.75, is for the delivery of 4564543492 - Oxcarbazepine 300 mg/5 ml suspension, 250 ml. The contract has an ultimate completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $2,874.78 and a period of performance through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.73, is for the delivery of oxcarbazepine 300 mg/5 ml suspension, a generic anticonvulsant medication, with a completion date of February 25, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The $4,104.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,568.42 contract is for the supply of 250 ml bottles of the medication Oxcarbazepine 300 mg/5 ml suspension. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,135.08, is for the delivery of a specific pharmaceutical product, OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, with an ultimate completion date of May 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,449,031 units of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The delivery order, valued at $1,453.15, has a firm fixed price and a completion date of January 26, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...